Covid-19 roundup: J&J, BARDA set early 2021 finish line for $1B vaccine race; FDA allows emergency drug use, ahead of pivotal data
J&J has zeroed in on a Covid-19 vaccine candidate that it hopes to begin testing in humans by September this year — with the extraordinary goal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
